Wit FW - Search Results

1

A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.

Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, Hoek FJ, van Straalen JP, Furrer H, Krediet RT, Reiss P; Prepare Study Group. Vrouenraets SM, et al. Among authors: wit fw. Clin Nephrol. 2012 Apr;77(4):311-20. doi: 10.5414/cn107214. Clin Nephrol. 2012. PMID: 22445475 Clinical Trial.

2

When to Start Antiretroviral Therapy and What to Start With-- A European Perspective.

Wit FW, Reiss P. Wit FW, et al. Curr Infect Dis Rep. 2003 Aug;5(4):349-357. doi: 10.1007/s11908-003-0013-y. Curr Infect Dis Rep. 2003. PMID: 12866987

3

Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.

Wit FW, Blanckenberg DH, Brinkman K, Prins JM, van der Ende ME, Schneider MM, Mulder JW, de Wolf F, Lange JM; ATHENA Study Group. Wit FW, et al. AIDS. 2005 Feb 18;19(3):345-8. AIDS. 2005. PMID: 15718848

4

Efavirenz: a review.

Vrouenraets SM, Wit FW, van Tongeren J, Lange JM. Vrouenraets SM, et al. Among authors: wit fw. Expert Opin Pharmacother. 2007 Apr;8(6):851-71. doi: 10.1517/14656566.8.6.851. Expert Opin Pharmacother. 2007. PMID: 17425480 Review.

5

Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

Wit FW, Kesselring AM, Gras L, Richter C, van der Ende ME, Brinkman K, Lange JM, de Wolf F, Reiss P. Wit FW, et al. Clin Infect Dis. 2008 Mar 15;46(6):933-40. doi: 10.1086/528861. Clin Infect Dis. 2008. PMID: 18271750 Clinical Trial.

6

High prevalence of reduced bone mineral density in primary HIV-1-infected men.

Grijsen ML, Vrouenraets SM, Steingrover R, Lips P, Reiss P, Wit FW, Prins JM. Grijsen ML, et al. Among authors: wit fw. AIDS. 2010 Sep 10;24(14):2233-8. doi: 10.1097/QAD.0b013e32833c93fe. AIDS. 2010. PMID: 20616695

7

Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.

Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Furrer H, Brinkman K, Hoek FJ, Abeling NG, Krediet RT, Reiss P; Prepare Study Group. Vrouenraets SM, et al. Among authors: wit fw. AIDS. 2011 Nov 13;25(17):2149-55. doi: 10.1097/QAD.0b013e32834bba87. AIDS. 2011. PMID: 21857491

8

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial.

Grijsen ML, Steingrover R, Wit FW, Jurriaans S, Verbon A, Brinkman K, van der Ende ME, Soetekouw R, de Wolf F, Lange JM, Schuitemaker H, Prins JM; Primo-SHM Study Group. Grijsen ML, et al. Among authors: wit fw. PLoS Med. 2012;9(3):e1001196. doi: 10.1371/journal.pmed.1001196. Epub 2012 Mar 27. PLoS Med. 2012. PMID: 22479156 Free PMC article. Clinical Trial.

9

Low bone mineral density, regardless of HIV status, in men who have sex with men.

Grijsen ML, Vrouenraets SM, Wit FW, Stolte IG, Prins M, Lips P, Reiss P, Prins JM. Grijsen ML, et al. Among authors: wit fw. J Infect Dis. 2013 Feb 1;207(3):386-91. doi: 10.1093/infdis/jis687. Epub 2012 Nov 12. J Infect Dis. 2013. PMID: 23148289

10

Temporary treatment during primary HIV infection does not affect virologic response to subsequent long-term treatment.

Grijsen ML, Wit FW, Jurriaans S, Kroon FP, Schippers EF, Koopmans P, Gras L, Lange JM, Prins JM; Primo-SHM Study Group. Grijsen ML, et al. Among authors: wit fw. PLoS One. 2014 Apr 3;9(4):e89639. doi: 10.1371/journal.pone.0089639. eCollection 2014. PLoS One. 2014. PMID: 24699072 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters